Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript

Page 5 of 5

Lawrence Weiss: Yes. Our quality systems are in place and very professional. So whatever the FDA throws at us, we feel like we can respond in a timely fashion.

Andrew Cooper: [Technical Difficulty]

Brandon Perthuis: Andrew, it sounds like you have some connectivity issues.

Andrew Cooper: I just said I would stop there. Hopefully you can hear me now. Apologies.

Brandon Perthuis: Yes, we can. Thank you, Andrew.

Operator: Thank you. We’ve reached the end of our question-and-answer session. And ladies and gentlemen, that does conclude today’s teleconference and webcast. You may disconnect your lines at this time and have a wonderful day. We thank you for your participation today.

Follow Fulgent Genetics Inc. (NASDAQ:FLGT)

Page 5 of 5